|
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: LRRCC1 |
Gene summary for LRRCC1 |
| Gene information | Species | Human | Gene symbol | LRRCC1 | Gene ID | 85444 |
| Gene name | leucine rich repeat and coiled-coil centrosomal protein 1 | |
| Gene Alias | CLERC | |
| Cytomap | 8q21.2 | |
| Gene Type | protein-coding | GO ID | GO:0007049 | UniProtAcc | B4DTJ0 |
Top |
Malignant transformation analysis |
Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
| Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
| 85444 | LRRCC1 | LZE2T | Human | Esophagus | ESCC | 2.69e-05 | 6.31e-01 | 0.082 |
| 85444 | LRRCC1 | LZE24T | Human | Esophagus | ESCC | 4.45e-09 | 3.08e-01 | 0.0596 |
| 85444 | LRRCC1 | P2T-E | Human | Esophagus | ESCC | 2.68e-38 | 7.71e-01 | 0.1177 |
| 85444 | LRRCC1 | P4T-E | Human | Esophagus | ESCC | 1.05e-29 | 6.74e-01 | 0.1323 |
| 85444 | LRRCC1 | P5T-E | Human | Esophagus | ESCC | 9.80e-07 | 2.04e-01 | 0.1327 |
| 85444 | LRRCC1 | P8T-E | Human | Esophagus | ESCC | 2.26e-09 | 2.31e-01 | 0.0889 |
| 85444 | LRRCC1 | P9T-E | Human | Esophagus | ESCC | 2.15e-08 | 1.61e-01 | 0.1131 |
| 85444 | LRRCC1 | P10T-E | Human | Esophagus | ESCC | 2.16e-14 | 3.06e-01 | 0.116 |
| 85444 | LRRCC1 | P11T-E | Human | Esophagus | ESCC | 6.23e-15 | 5.97e-01 | 0.1426 |
| 85444 | LRRCC1 | P12T-E | Human | Esophagus | ESCC | 9.54e-18 | 3.75e-01 | 0.1122 |
| 85444 | LRRCC1 | P15T-E | Human | Esophagus | ESCC | 1.56e-05 | 1.87e-01 | 0.1149 |
| 85444 | LRRCC1 | P16T-E | Human | Esophagus | ESCC | 1.06e-25 | 5.68e-01 | 0.1153 |
| 85444 | LRRCC1 | P17T-E | Human | Esophagus | ESCC | 1.03e-07 | 3.08e-01 | 0.1278 |
| 85444 | LRRCC1 | P19T-E | Human | Esophagus | ESCC | 1.68e-08 | 5.24e-01 | 0.1662 |
| 85444 | LRRCC1 | P20T-E | Human | Esophagus | ESCC | 1.52e-06 | 1.50e-01 | 0.1124 |
| 85444 | LRRCC1 | P21T-E | Human | Esophagus | ESCC | 1.18e-16 | 3.73e-01 | 0.1617 |
| 85444 | LRRCC1 | P22T-E | Human | Esophagus | ESCC | 5.77e-09 | 2.16e-01 | 0.1236 |
| 85444 | LRRCC1 | P23T-E | Human | Esophagus | ESCC | 9.65e-11 | 2.69e-01 | 0.108 |
| 85444 | LRRCC1 | P24T-E | Human | Esophagus | ESCC | 3.02e-16 | 3.22e-01 | 0.1287 |
| 85444 | LRRCC1 | P26T-E | Human | Esophagus | ESCC | 2.72e-10 | 1.99e-01 | 0.1276 |
| Page: 1 2 3 4 |
| ∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
| Tissue | Disease Stage | Enriched GO biological Processes |
| Colorectum | AD | ![]() |
| Colorectum | SER | ![]() |
| Colorectum | MSS | ![]() |
| Colorectum | MSI-H | ![]() |
| Colorectum | FAP | ![]() |
| ∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
| Page: 1 2 3 4 5 6 7 8 9 |
| GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
| Page: 1 |
| Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
| Page: 1 |
Top |
Cell-cell communication analysis |
Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
| Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
| Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
| TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
| ∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
| Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
Annotation of somatic variants for genes involved in malignant transformation |
| Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
| LRRCC1 | insertion | Frame_Shift_Ins | novel | c.646_647insCCGGAAT | p.Gln216ProfsTer13 | p.Q216Pfs*13 | Q9C099 | protein_coding | TCGA-FY-A4B0-01 | Thyroid | thyroid carcinoma | Male | >=65 | I/II | Hormone Therapy | synthroid | SD | ||
| LRRCC1 | insertion | Frame_Shift_Ins | novel | c.1528_1529insTACT | p.Ala510ValfsTer11 | p.A510Vfs*11 | Q9C099 | protein_coding | TCGA-FY-A4B0-01 | Thyroid | thyroid carcinoma | Male | >=65 | I/II | Hormone Therapy | synthroid | SD |
| Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 |
Top |
Related drugs of malignant transformation related genes |
Identification of chemicals and drugs interact with genes involved in malignant transfromation |
| (DGIdb 4.0) |
| Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
| Page: 1 |